Protocol_ID,Results_ID,Assay,Cell_source,Cell_bank,Cell_authentication,Cell_mycoplasma,Control_description,Abeta_sequence,Abeta_origin,Abeta_species,Abeta_aggregation,Single_exposure,Duration_hours,Concentration_uM,Passage_number,N_cells,N_cells_unit,N_cells_volume,Plate_size,Culture_medium,Medium_supplements,Serum_type,Serum_concentration,Diferentiation_method,Diferentiation_duration_days,Differentiation_medium,Differentiation_serum_type,Differentiation_serum_concentration,Differentiation_supplements,Differentiation_protocol,OBS
201,214,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-42,synthetic,Human,Monomers,"Yes, single",24.0,0.500,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
202,215,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-42,synthetic,Human,Monomers,"Yes, single",24.0,1.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
203,216,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-42,synthetic,Human,Monomers,"Yes, single",24.0,2.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
204,217,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-42,synthetic,Human,Monomers,"Yes, single",24.0,5.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
205,218,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-42,synthetic,Human,Monomers,"Yes, single",24.0,10.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
206,219,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-42,synthetic,Human,Monomers,"Yes, single",24.0,20.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
207,220,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,0.500,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
208,221,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,1.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
209,222,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,2.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
210,223,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,5.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
211,224,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,10.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
212,225,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,20.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
213,226,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-40,synthetic,Human,Monomers,"Yes, single",24.0,0.500,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
214,228,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-40,synthetic,Human,Monomers,"Yes, single",24.0,1.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
215,229,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-40,synthetic,Human,Monomers,"Yes, single",24.0,2.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
216,230,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-40,synthetic,Human,Monomers,"Yes, single",24.0,5.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
217,231,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-40,synthetic,Human,Monomers,"Yes, single",24.0,10.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
218,232,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-40,synthetic,Human,Monomers,"Yes, single",24.0,20.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
219,233,MTT,Cell bank,"European Collection of Authenticated Cell Cultures (Porton Down, UK)",No,No,Vehicle,1-43,synthetic,Human,Monomers,"Yes, single",24.0,10.000,Not informed,40000,cells/well,100.0,96,DMEM/F12 containing GlutaMAX-I,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells (ECACC No. 94030304). Once the cells were 80% confluent, they were used forexperimental purpose; immediately, the medium was replacedwith fresh Advanced DMEM/F12 containing GlutaMAXTM-I supple-mented with 3% FBS. The MTT reagent (15 uL) was then added per well, and the cells were incubated for an additional 4 h. The formazan crystalswere solubilized by adding 100 L/well of solubilizer (10% sodiumdodecyl sulphate (SDS), 3.2 mM HCl) and the plates were placedovernight at 37◦C. The absorbance (A570) of the resulting coloredsolution was measured with a microplate reader (iMark, Bio-Rad)."
220,234,MTT,Unclear,NA,No,No,Medium only,1-40,synthetic,Unclear,Fibers,"Yes, single",24.0,50.000,Not informed,300000,cells/ml,,96,DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Ab (1–40) was produced at the peptide synthesis facility of the University of W€urzburg with a
Zinsser simultaneous multiple peptide synthesiser using a Fmoc-protection and DIC=HOBt activating
chemistry as described previously (Loske et al., 2000). Purity of the peptide was judged by
analytical HPLC to be >98%; the correct molecular weight was confirmed by mass spectrometry
(MALDI-TOF).
Culture medium supplemented with streptomycin=penicillin (100 mg=ml; 100U=ml) and 2mM L-glutamine."
221,235,MTT,Unclear,NA,No,No,Medium only,1-40,synthetic,Unclear,Fibers,"Yes, single",24.0,100.000,Not informed,300000,cells/ml,,96,DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Ab (1–40) was produced at the peptide synthesis facility of the University of W€urzburg with a
Zinsser simultaneous multiple peptide synthesiser using a Fmoc-protection and DIC=HOBt activating
chemistry as described previously (Loske et al., 2000). Purity of the peptide was judged by
analytical HPLC to be >98%; the correct molecular weight was confirmed by mass spectrometry
(MALDI-TOF).
Culture medium supplemented with streptomycin=penicillin (100 mg=ml; 100U=ml) and 2mM L-glutamine."
222,236,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",0.0,5.000,Not informed,10000,cells/well,125.0,96,DMEM,,Inactivated fetal bovine serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,I had to check the company website to verify if the Abeta peptide used was synthetic. 2 mM L-glutamine and penicillin (100ug/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture.
223,237,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,5.000,Not informed,10000,cells/well,125.0,96,DMEM,,Inactivated fetal bovine serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,I had to check the company website to verify if the Abeta peptide used was synthetic. 2 mM L-glutamine and penicillin (100ug/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture.
224,238,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",48.0,5.000,Not informed,10000,cells/well,125.0,96,DMEM,,Inactivated fetal bovine serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,I had to check the company website to verify if the Abeta peptide used was synthetic. 2 mM L-glutamine and penicillin (100ug/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture.
225,239,MTT,Cell bank,"Cell Bank of Type Culture Collection of Academy of Sciences (Shanghai, China)",No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",24.0,5.000,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,The cell suspension volume plated was not informed in the paper.
226,240,MTT,Unclear,NA,No,No,Vehicle,,Unclear,Unclear,Unclear,"Yes, single",24.0,2.200,13,10000,cells/well,,96,MEM/F12,,NA,0,ATRA,7.0,MEM/F12,NA,NA,10 μM retinoic acid,"Briefly, 10000 SH-SY5Y cells (passage no. 13) were cultured in MEM/F12 media into each well of a 96-well plate. Cells were further differentiated with 10 μM retinoic acid for 1 week.","The Abeta peptide sequence is not informed in the paper. The concentration of Abeta used was estimated by the reviewer, considering the concentration informed on the figure (10ug/mL) and the molar mass of Abeta peptide as 4.5kDa (=4500g/mol). The cell suspension volume plated was not informed in the paper."
227,241,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,0.250,Not informed,,medium/well,100.0,96,high glucose modified Eagle’s medium (DMEM,,Fetal Bovine Serum,10%,Other,1.0,DMEM,Fetal Bovine Serum,1%,Only reduced serum,"SH-SY5Y cells were maintained
in high glucose modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum and penicillin
(100U/ml)/streptomycin (100 μg/ml) at 37°C with 5%
CO2. The medium was refreshed every two days. Before
experiments, SH-SY5Y cells were seeded in DMEM with
1% fetal bovine serum for 24 h.","The number of plated cells is not informed in the paper. Penicillin
(100U/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture."
228,242,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,0.500,Not informed,,medium/well,100.0,96,high glucose modified Eagle’s medium (DMEM,,Fetal Bovine Serum,10%,Other,1.0,DMEM,Fetal Bovine Serum,1%,Only reduced serum,"SH-SY5Y cells were maintained
in high glucose modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum and penicillin
(100U/ml)/streptomycin (100 μg/ml) at 37°C with 5%
CO2. The medium was refreshed every two days. Before
experiments, SH-SY5Y cells were seeded in DMEM with
1% fetal bovine serum for 24 h.","The number of plated cells is not informed in the paper. Penicillin
(100U/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture."
229,"243,247,245,246",MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,1.000,Not informed,,medium/well,100.0,96,high glucose modified Eagle’s medium (DMEM,,Fetal Bovine Serum,10%,Other,1.0,DMEM,Fetal Bovine Serum,1%,Only reduced serum,"SH-SY5Y cells were maintained
in high glucose modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum and penicillin
(100U/ml)/streptomycin (100 μg/ml) at 37°C with 5%
CO2. The medium was refreshed every two days. Before
experiments, SH-SY5Y cells were seeded in DMEM with
1% fetal bovine serum for 24 h.","The number of plated cells is not informed in the paper. Penicillin
(100U/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture."
230,244,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,1.500,Not informed,,medium/well,100.0,96,high glucose modified Eagle’s medium (DMEM,,Fetal Bovine Serum,10%,Other,1.0,DMEM,Fetal Bovine Serum,1%,Only reduced serum,"SH-SY5Y cells were maintained
in high glucose modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum and penicillin
(100U/ml)/streptomycin (100 μg/ml) at 37°C with 5%
CO2. The medium was refreshed every two days. Before
experiments, SH-SY5Y cells were seeded in DMEM with
1% fetal bovine serum for 24 h.","The number of plated cells is not informed in the paper. Penicillin
(100U/ml)/streptomycin (100 μg/ml) was also added to the culture medium to maintain cell culture."
231,248,CCK-8,Cell bank,"American Type Culture Collection, ATCC, Shanghai, China",No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",24.0,1.000,Not informed,,Not informed,,,DMEM,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,Even checking the company website that produced the Abeta used in this study (Sigma) it is not clear the origin or the species this peptide come from. The number of plated cells and the size of the plate are not informed in the paper. 1% Penicillin and streptomycin were also added to the culture medium to maintain cell culture.
232,249,CCK-8,Cell bank,"American Type Culture Collection, ATCC, Shanghai, China",No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",24.0,2.000,Not informed,,Not informed,,,DMEM,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,Even checking the company website that produced the Abeta used in this study (Sigma) it is not clear the origin or the species this peptide come from. The number of plated cells and the size of the plate are not informed in the paper. 1% Penicillin and streptomycin were also added to the culture medium to maintain cell culture.
233,"250,251",CCK-8,Cell bank,"American Type Culture Collection, ATCC, Shanghai, China",No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",24.0,5.000,Not informed,,Not informed,,,DMEM,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,Even checking the company website that produced the Abeta used in this study (Sigma) it is not clear the origin or the species this peptide come from. The number of plated cells and the size of the plate are not informed in the paper. 1% Penicillin and streptomycin were also added to the culture medium to maintain cell culture.
234,252,MTT,Unclear,NA,No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,,cells/well,,96,RPMI-1640,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Medium was changed every three days and cells were passed once they reached approximately 80% confluence. The volume of cell suspension plated for the experiment is not informed in the paper. 50 ug/ml penicillin-streptomycin and OPI (150 ug/ml oxaloacetate, 50 ug/ml pyruvate and 0.2 U/ml insulin) were also added to the culture medium to maintain cell culture. The cells were allowed to attach and grow for two days prior to the treatment with Abeta peptide."
235,253,MTT,Unclear,NA,No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",48.0,40.000,Not informed,,cells/well,,96,RPMI-1640,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Medium was changed every three days and cells were passed once they reached approximately 80% confluence. The volume of cell suspension plated for the experiment is not informed in the paper. 50 ug/ml penicillin-streptomycin and OPI (150 ug/ml oxaloacetate, 50 ug/ml pyruvate and 0.2 U/ml insulin) were also added to the culture medium to maintain cell culture. The cells were allowed to attach and grow for two days prior to the treatment with Abeta peptide."
236,254,MTT,Unclear,NA,No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",48.0,60.000,Not informed,,cells/well,,96,RPMI-1640,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Medium was changed every three days and cells were passed once they reached approximately 80% confluence. The volume of cell suspension plated for the experiment is not informed in the paper. 50 ug/ml penicillin-streptomycin and OPI (150 ug/ml oxaloacetate, 50 ug/ml pyruvate and 0.2 U/ml insulin) were also added to the culture medium to maintain cell culture. The cells were allowed to attach and grow for two days prior to the treatment with Abeta peptide."
237,255,MTT,Unclear,NA,No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",48.0,80.000,Not informed,,cells/well,,96,RPMI-1640,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Medium was changed every three days and cells were passed once they reached approximately 80% confluence. The volume of cell suspension plated for the experiment is not informed in the paper. 50 ug/ml penicillin-streptomycin and OPI (150 ug/ml oxaloacetate, 50 ug/ml pyruvate and 0.2 U/ml insulin) were also added to the culture medium to maintain cell culture. The cells were allowed to attach and grow for two days prior to the treatment with Abeta peptide."
238,256,MTT,Unclear,NA,No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",48.0,100.000,Not informed,,cells/well,,96,RPMI-1640,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Medium was changed every three days and cells were passed once they reached approximately 80% confluence. The volume of cell suspension plated for the experiment is not informed in the paper. 50 ug/ml penicillin-streptomycin and OPI (150 ug/ml oxaloacetate, 50 ug/ml pyruvate and 0.2 U/ml insulin) were also added to the culture medium to maintain cell culture. The cells were allowed to attach and grow for two days prior to the treatment with Abeta peptide."
239,257,MTT,Unclear,NA,No,No,Unlear,1-40,Unclear,Unclear,Unclear,"Yes, single",48.0,120.000,Not informed,,cells/well,,96,RPMI-1640,,Fetal Bovine Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"Medium was changed every three days and cells were passed once they reached approximately 80% confluence. The volume of cell suspension plated for the experiment is not informed in the paper. 50 ug/ml penicillin-streptomycin and OPI (150 ug/ml oxaloacetate, 50 ug/ml pyruvate and 0.2 U/ml insulin) were also added to the culture medium to maintain cell culture. The cells were allowed to attach and grow for two days prior to the treatment with Abeta peptide."
240,"258,262",WST,Unclear,NA,No,No,Vehicle,1-40,synthetic,Unclear,Oligomers,"Yes, single",24.0,20.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
241,"259,263",WST,Unclear,NA,No,No,Vehicle,1-40,synthetic,Unclear,Oligomers,"Yes, single",24.0,80.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
242,"260,264",WST,Unclear,NA,No,No,Vehicle,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,10.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
243,"261,265",WST,Unclear,NA,No,No,Vehicle,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,32.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
244,266,WST,Unclear,NA,No,No,Vehicle,1-40,synthetic,Unclear,Oligomers,"Yes, single",24.0,10.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
245,267,WST,Unclear,NA,No,No,Vehicle,1-40,synthetic,Unclear,Oligomers,"Yes, single",24.0,48.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
246,"268,271",WST,Unclear,NA,No,No,Vehicle,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,5.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
247,269,WST,Unclear,NA,No,No,Vehicle,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,10.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
248,270,WST,Unclear,NA,No,No,Vehicle,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,3.000,Under 20 passages,20000,cells/well,,96,1:1 mixture of F12 Ham and DMEM,,Fetal Calf Serum,10%,No differentiation,0.0,NA,NA,NA,NA,NA,"For cell viability experiments the cells were incubated for 24 h with different Ab preparations or the corresponding volumes of buffer (10mMHEPES, 100mMNaCl, 0.5 mM EDTA at pH 7.4) as a control, which is named here as the Abeta vehicle. The volume of cell suspension plated for the experiment is not informed in the paper. The culture medium was replaced with free FCS medium for the incubation of the cells with the different Ab preparations."
249,272,MTS,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",72.0,5.000,Not informed,10000,cells/well,,96,Not informed,,Not informed,Not informed,No differentiation,0.0,NA,NA,NA,NA,NA,"The data were reported as the percentage standardized change compared with sample-free controls, after correction for reagent blanks. The volume of cell suspension plated for the experiment is not informed in the paper. This paper references how the cell cultures were maintained.
"
250,273,MTS,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",72.0,10.000,Not informed,10000,cells/well,,96,Not informed,,Not informed,Not informed,No differentiation,0.0,NA,NA,NA,NA,NA,"The data were reported as the percentage standardized change compared with sample-free controls, after correction for reagent blanks. The volume of cell suspension plated for the experiment is not informed in the paper. This paper references how the cell cultures were maintained.
"
251,274,MTS,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",72.0,20.000,Not informed,10000,cells/well,,96,Not informed,,Not informed,Not informed,No differentiation,0.0,NA,NA,NA,NA,NA,"The data were reported as the percentage standardized change compared with sample-free controls, after correction for reagent blanks. The volume of cell suspension plated for the experiment is not informed in the paper. This paper references how the cell cultures were maintained.
"
252,275,MTS,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",72.0,30.000,Not informed,10000,cells/well,,96,Not informed,,Not informed,Not informed,No differentiation,0.0,NA,NA,NA,NA,NA,"The data were reported as the percentage standardized change compared with sample-free controls, after correction for reagent blanks. The volume of cell suspension plated for the experiment is not informed in the paper. This paper references how the cell cultures were maintained.
"
253,276,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",48.0,10.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
254,277,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",24.0,10.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
255,278,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",48.0,1.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
256,279,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",48.0,5.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
257,280,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",48.0,10.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
258,281,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",48.0,50.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
259,282,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",48.0,100.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
260,283,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",24.0,1.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
261,284,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",24.0,5.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
262,285,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",24.0,10.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
263,286,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",24.0,50.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
264,287,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Human,Oligomers,"Yes, single",24.0,100.000,Not informed,10000,cells/well,100.0,96,1:1 DMEM/Ham's F12,,Unclear,Unclear,Other,3.0,1:1 DMEM/Ham's F12,Unclear,Unclear,NA,"Every 24 h for three days, the medium was changed to obtain a well-adhered population of differentiated neuroblastoma cells.",SH-SY5Y cells were cultured until the mid-log phase
265,"288,289",MTT,Cell bank,"DSMZ, Braunschweig, Germany",No,No,Vehicle,1-42,synthetic,Unclear,Unclear,"Yes, single",120.0,0.500,Not informed,,,,,1:1 DMEM/ F12,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,Cell bank cell code DSMZ No. ACC 209. The number of cells plated for the experiment is not clear. The culture medium was supplemented with 2 mM L-glutamine and 1% penicillin/streptomycin.
266,290,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",24.0,0.100,Not informed,50000,cells/well,,96,DMEM,,Fetal Calf Serum and Fetal Horse Serum,10% and 5%,No differentiation,,NA,NA,NA,NA,NA,"Cells were passaged every 3–4 days. The volume of cell suspension plated for the experiment is not informed in the paper.  Cells were cultivated in medium supplemented with 2 mM Glutamax and 1% (v/v) penicillin/streptomycin.
"
267,291,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",24.0,0.500,Not informed,50000,cells/well,,96,DMEM,,,,No differentiation,,NA,NA,NA,NA,NA,"Cells were passaged every 3–4 days. The volume of cell suspension plated for the experiment is not informed in the paper.  Cells were cultivated in medium supplemented with 2 mM Glutamax and 1% (v/v) penicillin/streptomycin.
"
268,292,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",24.0,1.000,Not informed,50000,cells/well,,96,DMEM,,,,No differentiation,,NA,NA,NA,NA,NA,"Cells were passaged every 3–4 days. The volume of cell suspension plated for the experiment is not informed in the paper.  Cells were cultivated in medium supplemented with 2 mM Glutamax and 1% (v/v) penicillin/streptomycin.
"
269,293,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",24.0,12.000,Not informed,50000,cells/well,,96,DMEM,,,,No differentiation,,NA,NA,NA,NA,NA,"Cells were passaged every 3–4 days. The volume of cell suspension plated for the experiment is not informed in the paper.  Cells were cultivated in medium supplemented with 2 mM Glutamax and 1% (v/v) penicillin/streptomycin.
"
270,"294,296",MTT,Cell bank,"European Collection of Authenticated Cell Culture, Sigma-Aldrich (St.
Louis, MO, USA)",No,No,Other,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,1.000,Not informed,,,,96,F12/ MEM,"1% non-essential amino acids, 50 U/ml penicillin, and 50 μg/ml
streptomycin as well as L-glutamine",heat-inactivated Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Aβ1-42 with scrambled sequence (Aβscr, the same composition of amino acids but in random order), which was subjected to the same oligomerization protocol, was used as a negative control (data not shown)."
271,298,MTT,Cell bank,"ECACC, Public Health Englangd, UK",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,10.000,Not informed,,Not informed,,,DMEM,2 mM L-glutamine; 100 units/ml of penicillin and 100 μg/ml streptomycin,fetal calf serum,10%,No differentiation,,NA,NA,NA,NA,NA," The volume of cell suspension plated for the experiment is not informed in the paper, nor does the plate size used. "
272,299,MTT,Unclear,NA,No,No,Vehicle,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,5.000,Not informed,30000,cells/well,,96,DMEM/ F12,1% Glutamine,fetal calf serum,10%,No differentiation,,NA,NA,NA,NA,NA, The volume of cell suspension plated for the experiment is not informed in the paper.
273,300,MTT,Unclear,NA,No,No,Vehicle,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,1.000,Not informed,30000,cells/well,,96,DMEM/ F12,1% Glutamine,fetal calf serum,10%,No differentiation,,NA,NA,NA,NA,NA, The volume of cell suspension plated for the experiment is not informed in the paper.
274,301,WST,Cell bank,ATCC,No,No,Vehicle,1-40,Unclear,Unclear,Oligomers,"Yes, single",24.0,,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
275,"302,303",WST,Cell bank,ATCC,No,No,Vehicle,1-40,Unclear,Unclear,Fibers,"Yes, single",24.0,,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
276,304,WST,Cell bank,ATCC,No,No,Vehicle,1-40,Unclear,Unclear,Oligomers,"Yes, single",48.0,,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
277,"305,306",WST,Cell bank,ATCC,No,No,Vehicle,1-40,Unclear,Unclear,Fibers,"Yes, single",48.0,,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
278,307,WST,Cell bank,ATCC,No,No,Vehicle,1-40,Unclear,Unclear,Oligomers,"Yes, single",72.0,,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
279,"308,309",WST,Cell bank,ATCC,No,No,Vehicle,1-40,Unclear,Unclear,Fibers,"Yes, single",72.0,,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
280,310,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",24.0,22.200,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
281,311,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",24.0,44.400,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
282,312,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",24.0,66.600,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
283,313,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",24.0,88.800,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
284,314,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",24.0,111.000,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
285,315,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",48.0,22.200,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
286,316,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",48.0,44.400,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
287,317,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",48.0,66.600,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
288,318,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",48.0,88.800,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
289,319,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",48.0,111.000,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
290,320,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",72.0,22.200,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
291,321,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",72.0,44.400,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
292,322,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",72.0,66.600,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
293,323,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",72.0,88.800,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
294,324,WST,Cell bank,ATCC,No,No,Medium only,1-40,Unclear,Unclear,Fibers,"Yes, single",72.0,111.000,Not informed,10000,cells/well,,96,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"ATCC CRL-2266. Aβ(1−40) was produced by Alexotech (Umea, Sweden)."
295,325,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,1.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
296,326,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,3.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
297,327,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,5.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
298,328,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,10.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
299,329,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
300,330,MTT,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,50.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
301,331,MTT,Unclear,NA,No,No,Medium only,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,1.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
302,332,MTT,Unclear,NA,No,No,Medium only,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,3.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
303,333,MTT,Unclear,NA,No,No,Medium only,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,5.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
304,334,MTT,Unclear,NA,No,No,Medium only,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,10.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
305,335,MTT,Unclear,NA,No,No,Medium only,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
306,336,MTT,Unclear,NA,No,No,Medium only,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,50.000,Not informed,100000,cells/well,,24,,,,,,,,,,,,All the cell cultures treatment ans maintenance were absent in the paper.
307,337,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Oligomers,"Yes, single",48.0,1.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The SEC assay on this papers shows that the molecular weight of Abeta aggregates is 20-29kDa, which corresponds to Abeta Oligomers. Abeta fibrils are not soluble, so they could not enter the SEC column."
308,338,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Oligomers,"Yes, single",48.0,2.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The SEC assay on this papers shows that the molecular weight of Abeta aggregates is 20-29kDa, which corresponds to Abeta Oligomers. Abeta fibrils are not soluble, so they could not enter the SEC column."
309,339,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Oligomers,"Yes, single",48.0,4.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The SEC assay on this papers shows that the molecular weight of Abeta aggregates is 20-29kDa, which corresponds to Abeta Oligomers. Abeta fibrils are not soluble, so they could not enter the SEC column."
310,340,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,1.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The authors did not perform SEC analysis to synthetic Abeta.
311,341,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,2.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The authors did not perform SEC analysis to synthetic Abeta.
312,342,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,4.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The authors did not perform SEC analysis to synthetic Abeta.
313,343,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Oligomers,"Yes, single",12.0,5.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The SEC assay on this papers shows that the molecular weight of Abeta aggregates is 20-29kDa, which corresponds to Abeta Oligomers. Abeta fibrils are not soluble, so they could not enter the SEC column."
314,344,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Oligomers,"Yes, single",24.0,5.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The SEC assay on this papers shows that the molecular weight of Abeta aggregates is 20-29kDa, which corresponds to Abeta Oligomers. Abeta fibrils are not soluble, so they could not enter the SEC column."
315,345,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Oligomers,"Yes, single",48.0,5.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The SEC assay on this papers shows that the molecular weight of Abeta aggregates is 20-29kDa, which corresponds to Abeta Oligomers. Abeta fibrils are not soluble, so they could not enter the SEC column."
316,346,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Unclear,"Yes, single",12.0,5.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The authors did not perform SEC analysis to synthetic Abeta.
317,347,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Unclear,"Yes, single",24.0,5.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The authors did not perform SEC analysis to synthetic Abeta.
318,348,MTT,Unclear,NA,No,No,Unlear,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,5.000,Not informed,700000,cells/well,,12,DMEM,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The authors did not perform SEC analysis to synthetic Abeta.
319,349,WST,Donation,"Isoda Laboratory, University of Tsukuba, Japan",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,1.500,Not informed,10000,cells/well,100.0,96,DMEM/ Ham's F12 ,1% non-essential MEM amino acid and 1% penicillin (5000 μg/ml)-streptomycin (5000 IU/ml) solution,Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Cell attachment was required for toxicity assays; hence, the plates were pretreated overnight with 50 μg/ml fibronectin,
which was refined from human plasma."
320,350,WST,Donation,"Isoda Laboratory, University of Tsukuba, Japan",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,10.000,Not informed,10000,cells/well,100.0,96,DMEM/ Ham's F12 ,1% non-essential MEM amino acid and 1% penicillin (5000 μg/ml)-streptomycin (5000 IU/ml) solution,Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Cell attachment was required for toxicity assays; hence, the plates were pretreated overnight with 50 μg/ml fibronectin,
which was refined from human plasma."
321,351,WST,Donation,"Isoda Laboratory, University of Tsukuba, Japan",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,12.500,Not informed,10000,cells/well,100.0,96,DMEM/ Ham's F12 ,1% non-essential MEM amino acid and 1% penicillin (5000 μg/ml)-streptomycin (5000 IU/ml) solution,Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Cell attachment was required for toxicity assays; hence, the plates were pretreated overnight with 50 μg/ml fibronectin,
which was refined from human plasma."
322,352,WST,Donation,"Isoda Laboratory, University of Tsukuba, Japan",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,15.000,Not informed,10000,cells/well,100.0,96,DMEM/ Ham's F12 ,1% non-essential MEM amino acid and 1% penicillin (5000 μg/ml)-streptomycin (5000 IU/ml) solution,Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Cell attachment was required for toxicity assays; hence, the plates were pretreated overnight with 50 μg/ml fibronectin,
which was refined from human plasma."
323,353,WST,Donation,"Isoda Laboratory, University of Tsukuba, Japan",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,10000,cells/well,100.0,96,DMEM/ Ham's F12 ,1% non-essential MEM amino acid and 1% penicillin (5000 μg/ml)-streptomycin (5000 IU/ml) solution,Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Cell attachment was required for toxicity assays; hence, the plates were pretreated overnight with 50 μg/ml fibronectin,
which was refined from human plasma."
324,354,WST,Donation,"Isoda Laboratory, University of Tsukuba, Japan",No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,10000,cells/well,100.0,96,DMEM/ Ham's F12 ,1% non-essential MEM amino acid and 1% penicillin (5000 μg/ml)-streptomycin (5000 IU/ml) solution,Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Cell attachment was required for toxicity assays; hence, the plates were pretreated overnight with 50 μg/ml fibronectin,
which was refined from human plasma."
325,355,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Human,Unclear,"Yes, single",12.0,0.001,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
326,356,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Human,Unclear,"Yes, single",12.0,0.010,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
327,357,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Human,Unclear,"Yes, single",12.0,0.100,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
328,358,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Human,Unclear,"Yes, single",12.0,1.000,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
329,359,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Human,Unclear,"Yes, single",12.0,10.000,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
330,360,MTT,Unclear,NA,No,No,Unlear,1-40,recombinant,Human,Unclear,"Yes, single",12.0,0.001,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
331,361,MTT,Unclear,NA,No,No,Unlear,1-40,recombinant,Human,Unclear,"Yes, single",12.0,0.010,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
332,362,MTT,Unclear,NA,No,No,Unlear,1-40,recombinant,Human,Unclear,"Yes, single",12.0,0.100,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
333,363,MTT,Unclear,NA,No,No,Unlear,1-40,recombinant,Human,Unclear,"Yes, single",12.0,1.000,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
334,364,MTT,Unclear,NA,No,No,Unlear,1-40,recombinant,Human,Unclear,"Yes, single",12.0,10.000,Not informed,15000,cells/well,,96,1:1 DMEM/Ham's F12,1% (v/v) antibiotics,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
335,365,MTT,Unclear,NA,No,No,Vehicle,1-42,recombinant,Unclear,Oligomers,"Yes, single",24.0,10.000,Under 19 passages,10000,cells/well,,96,DMEM,1% Penicillin-Streptomycin and 2 mM L-Glutamine,fetal calf serum,10%,No differentiation,,NA,NA,NA,NA,NA,Cells were passed every 4–5 days at around 80% confluency and not used beyond passage 19.
336,366,MTT,Unclear,NA,No,No,Vehicle,1-42,recombinant,Unclear,Oligomers,"Yes, single",48.0,10.000,Under 19 passages,10000,cells/well,,96,DMEM,1% Penicillin-Streptomycin and 2 mM L-Glutamine,fetal calf serum,10%,No differentiation,,NA,NA,NA,NA,NA,Cells were passed every 4–5 days at around 80% confluency and not used beyond passage 19.
337,367,WST,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,2.500,Not informed,,,,,DMEM,"penicillin (20 units/ml), and streptomycin (20 mg/ml)",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The number of cells plated for the experiments is not informed in the paper.
338,368,WST,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,5.000,Not informed,,,,,DMEM,"penicillin (20 units/ml), and streptomycin (20 mg/ml)",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The number of cells plated for the experiments is not informed in the paper.
339,"369,371",WST,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,7.500,Not informed,,,,,DMEM,"penicillin (20 units/ml), and streptomycin (20 mg/ml)",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The number of cells plated for the experiments is not informed in the paper.
340,370,WST,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,10.000,Not informed,,,,,DMEM,"penicillin (20 units/ml), and streptomycin (20 mg/ml)",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The number of cells plated for the experiments is not informed in the paper.
341,372,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",48.0,2.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266)"
342,373,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",48.0,4.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
343,374,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",48.0,8.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
344,375,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",48.0,16.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
345,376,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Fibers,"Yes, single",48.0,2.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
346,377,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Fibers,"Yes, single",48.0,4.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
347,378,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Fibers,"Yes, single",48.0,8.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
348,379,XTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Fibers,"Yes, single",48.0,16.000,Not informed,,,,,1:1 DMEM/Ham's F12,1% penicillin–streptomycin,Fetal Bovine Serum,10%,ATRA plus,7.0,1:1 DMEM/Ham's F12,Fetal Bovine Serum,10%,"1% penicillin–streptomycin, 10 μM all-trans retinoic acid, 50 ng/ml brain-derived neurotrophic factor","SH-SY5Y (ATCC, Manassas, VA; CRL-2266) was maintained
in a 1:1 Dulbecco’s Modified Eagle’s Medium
(Invitrogen, Carlsbad, CA)/Ham’s F-12 nutrient mixture
(Biosource, Camarillo, CA) supplemented with 10 % fetal
bovine serum (Invitrogen, Carlsbad, CA) and 1 % penicillin–
streptomycin (Invitrogen, Carlsbad, CA) (DF medium)
at 37°C in a humidified chamber with 5 % CO2. For neuronal
differentiation, a modification of the method of Encinas
et al. (2000) showed that a 3d BDNF exposure produced~
90 % of cells arrested in G1-phase. Cells (10,000 cm2) were
first plated in DF medium plus 10 μM all-trans retinoic acid
(RA; Sigma-Aldrich, St. Louis, MO) and cultured for 3 days.
Then the medium was changed to serum-free DF medium
plus 50 ng/ml brain-derived neurotrophic factor (BDNF; Chemicon, Temecula, CA), and cells were incubated for another 4 days.","Cell origin: ATCC, Manassas, VA; CRL-2266). The number of cells plated for the experiments is not informed in the paper."
349,"380,381",MTS,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,5.000,Not informed,20000,cells/well,,96,Optimem,,,,No differentiation,,NA,NA,NA,NA,NA,
350,"295,297",MTT,Cell bank,"European Collection of Authenticated Cell Culture, Sigma-Aldrich (St.
Louis, MO, USA)",No,No,Other,1-42,Unclear,Unclear,Oligomers,"Yes, single",48.0,1.000,Not informed,,,,96,F12/ MEM,"1% non-essential amino acids, 50 U/ml penicillin, and 50 μg/ml
streptomycin as well as L-glutamine",heat-inactivated Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"Aβ1-42 with scrambled sequence (Aβscr, the same composition of amino acids but in random order), which was subjected to the same oligomerization protocol, was used as a negative control (data not shown)."
351,382,MTT,Donation,"The human neuroblastoma SH-SY5Y cell line was a gift from Dr. R. Ross, Fordham University, NY",No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",72.0,30.000,Not informed,500000,cell/well,1000.0,24,DMEM/ F12,,Fetal Bovine Serum,5%,ATRA,4.0,DMEM/ F12,Fetal Bovine Serum,5%,"100 IU/mL penicillin, and 100 ug/mL streptomycin, 5 uM retinoic acid","To achieve SH-SY5Y differentiation, the undifferentiated cells were treated for 4 days with 5 uM retinoic acid (RA) in DMEM/F12 medium containing 5% FBS, 100 IU/mL penicillin, and 100 ug/mL
streptomycin. The RA-containing medium was
changed every two days.",
353,383,CCK-8,Cell bank,"Shanghai Cell Bank, Chinese Academy of Sciences (Shanghai, China)",No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",0.0,222000.000,Not informed,,,,,DMEM/ F12,1% penicillin–streptomycin solution,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,There are 2 descriptions for Ab treatement present in methods section: items 2.1 and 2.2.
354,384,CCK-8,Cell bank,"Shanghai Cell Bank, Chinese Academy of Sciences (Shanghai, China)",No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",6.0,222000.000,Not informed,,,,,DMEM/ F12,1% penicillin–streptomycin solution,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,There are 2 descriptions for Ab treatement present in methods section: items 2.1 and 2.2.
355,"385,386",MTS,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",72.0,10.000,3-4,300000,cell/mL,,96,1:1 DMEM/F12,2 mM L-glutamine; 1% of antibiotics including penicillin and streptomycin,Fetal Bovine Serum,10%,ATRA,1.0,1:1 DMEM/ F12,Fetal Bovine Serum,1%,10uM ATRA,"Cell cultures with
three to four passages were used for the experiments in compliance with
ATCC recommendation. After reaching 70−80% confluence, cells were
subcultured on poly(D-lysine) plates with 10 μM retinoic acid in a
reduced serum media (1% FBS) to induce postmitotic differentiation.27
Differentiation was confirmed by the change to polygonal morphology
and extension of long neurites.

SH-SY5Y human
neuroblastoma cells were seeded at a density of 3 × 105 cells/mL in a
6-well or 96-well poly(D-lysine) plate or a 10 cm poly(D-lysine) culture
dish in DMEM/F12 media containing 10 μMretinoic acid and 1% FBS
to induce postmitotic differentiation. The cells were incubated under
regular culture conditions for attachment. After 24 h of plating, the cells
were pretreated with different concentrations of test chemicals or a
vehicle control for 1 h following co-incubation with 5 or 10 μM Aβ42
during a desired time period.","The SH-SY5Y human neuroblastoma cell line was obtained from ATCC CRL-2266; Sigma-Aldrich, Saint Louis, MO. The results were normalized as the percentage of the neuroprotective activity relative to the Aβ42 free control (100%) and the 10 μMAβ42 treatment (0%). Cell cultures with three to four passages were used for the experiments in compliance with ATCC recommendation. The volume of cell suspension plated in 96 well plates is not informed."
356,387,MTT,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Unclear,"Yes, single",24.0,30.000,12,100000,cell/well,,48,1:1 EMEM/Ham's F12,"15 nonessential amino acids, 1 mM sodium pyruvate, 100 units/mL penicillin, and 100 μg/mL streptomycin",heat-inactivated Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,All the cells used in this study were used at a low passage number (<13).
357,388,MTT,Cell bank,ATCC,No,No,Vehicle,1-42,Unclear,Unclear,Unclear,"Yes, single",16.0,1.000,Not informed,10000,cell/well,,,1:1 EMEM/Ham's F12,,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"SH-SY5Y cells were obtained from ATCC, Manassas, VA. The plate size is not informed in the paper."
358,389,MTT,Cell bank,ECACC,No,No,Unlear,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,0.500,Not informed,80000,cell/well,100.0,96,1:1 DMEM/F12,"L-glutamine, 15mM Hepes, Penicillin (100 units/ml; Gibco) and streptomycin
(100ug/ml; Gibco), MEM non-essential amino acids (100×; Sigma–Aldrich)",Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells were purchased from ECACC (European Collection of Cell Culture, Salisbury, UK)."
360,"393,394",MTT,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",48.0,1.000,Not informed,10000,cell/well,,96,1:1 MEM/Ham's F12,1% L-glutamine (3.6 mM),Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
361,395,MTT,Unclear,NA,No,No,Medium only,1-42,Unclear,Unclear,Fibers,"Yes, single",24.0,,Not informed,5000,cell/well,,96,DMEM,100 U/ml penicillin.,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
362,396,MTT,Cell bank,ATCC,No,No,Unlear,1-42,synthetic,Human,Unclear,"Yes, single",24.0,0.200,Not informed,20000,cell/well,,96,DMEM,1% penicillin G-streptomycin,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"SH-SY5Y human neuroblastoma cells were obtained from American Type Culture Collection (ATCC, Manassas, VA)."
364,399,MTS,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",48.0,7.000,46,10000,cell/well,,96,DMEM,1% Pen-Strep,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The cells were plated at a concentration of 10.000 cells per well on collagen I coated 96-well plates.
365,400,MTS,Unclear,NA,No,No,Medium only,1-42,synthetic,Unclear,Fibers,"Yes, single",48.0,7.000,46,10000,cell/well,,96,DMEM,1% Pen-Strep,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,The cells were plated at a concentration of 10.000 cells per well on collagen I coated 96-well plates.
366,401,MTT,Cell bank,ATCC,No,No,Unlear,1-42,synthetic,Human,Fibers,"Yes, single",24.0,20.000,Not informed,20000,cell/well,,96,DMEM High glucose,"1% L-glutamine (3.6 mM), and 1% penicillin/streptomycin",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"The human SH-SY5Y neuronal cell line was obtained from American Type Culture Collection, Manassas, VA"
367,402,MTT,Unclear,NA,No,No,Vehicle,1-42,synthetic,Human,Unclear,"Yes, single",48.0,2.500,Not informed,38000,cell/well,,96,DMEM/ F12,1% Glutamine,Fetal Calf Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
368,403,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",24.0,2.000,Not informed,100000,cell/mL,,96,Nutrient Mixture F-12,1% antibiotic-antimycotic,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
369,404,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,2.000,Not informed,100000,cell/mL,,96,Nutrient Mixture F-12,1% antibiotic-antimycotic,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
370,"405,407",MTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",24.0,125.000,Not informed,100000,cell/well,200.0,96,1 EMEM : Ham's F12,1% penicillin/streptomycin,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"Human neuroblastoma SH-SY5Y cell line was from ATCC, Manassas,VA."
371,"406,408",MTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Unclear,"Yes, single",48.0,125.000,Not informed,100000,cell/well,200.0,96,1 EMEM : Ham's F12,1% penicillin/streptomycin,Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,"Human neuroblastoma SH-SY5Y cell line was from ATCC, Manassas,VA."
372,"409,411",MTT,Cell bank,Pasteur Institute of Iran,No,No,Medium only,1-42,Unclear,Unclear,Unclear,"Yes, single",24.0,20.000,Not informed,5000,cell/well,,96,DMEM,"2 mM L-glutamine, penicillin 100 units/ml, streptomycin 100 μg/ml",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
373,410,MTT,Cell bank,Pasteur Institute of Iran,No,No,Medium only,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,5000,cell/well,,96,DMEM,"2 mM L-glutamine, penicillin 100 units/ml, streptomycin 100 μg/ml",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
374,390,CCK-8,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,0.300,Not informed,400000,cell/well,,96,DMEM,"penicillin 100 units/ml, streptomycin 100 μg/ml",Fetal Bovine Serum and Horse Serum,5% of each,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide was obtained from Peptide Institute, Incorporation, Osaka, Japan). The 96 well plates used were coated with poly-D-lysine.
Authors described serum reduction for 24h after cell plating in cell viability experiments. However, they do not mention this as cell differentiation."
375,391,CCK-8,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,0.300,Not informed,400000,cell/well,,96,DMEM,"penicillin 100 units/ml, streptomycin 100 μg/ml",Fetal Bovine Serum and Horse Serum,5% of each,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide was obtained from Peptide Institute, Incorporation, Osaka, Japan). The 96 well plates used were coated with poly-D-lysine.
Authors described serum reduction for 24h after cell plating in cell viability experiments. However, they do not mention this as cell differentiation."
376,392,CCK-8,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Oligomers,"Yes, single",24.0,0.300,Not informed,400000,cell/well,,96,DMEM,"penicillin 100 units/ml, streptomycin 100 μg/ml",Fetal Bovine Serum and Horse Serum,5% of each,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide was obtained from Peptide Institute, Incorporation, Osaka, Japan). The 96 well plates used were coated with poly-D-lysine.
Authors described serum reduction for 24h after cell plating in cell viability experiments. However, they do not mention this as cell differentiation."
377,397,MTT,Cell bank,"Institute of Biochemistry and Cell Biology, Shangai Institute for Biological Sciences, CAS (Shangai,China)",No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",48.0,20.000,Not informed,10000,cell/well,100.0,96,DMEM,2 mM L-glutamine,Fetal Calf Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
378,398,MTT,Cell bank,"Institute of Biochemistry and Cell Biology, Shangai Institute for Biological Sciences, CAS (Shangai,China)",No,No,Medium only,1-42,Unclear,Unclear,Oligomers,"Yes, single",48.0,20.000,Not informed,10000,cell/well,100.0,96,DMEM,2 mM L-glutamine,Fetal Calf Serum,10%,No differentiation,,NA,NA,NA,NA,NA,
379,412,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,1.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide used for these experiments were purchased from Covance (Dedham, MA)."
380,413,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,3.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide used for these experiments were purchased from Covance (Dedham, MA)."
381,414,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,5.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide used for these experiments were purchased from Covance (Dedham, MA)."
382,415,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,10.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide used for these experiments were purchased from Covance (Dedham, MA)."
383,416,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide used for these experiments were purchased from Covance (Dedham, MA)."
384,417,MTT,Unclear,NA,No,No,Unlear,1-42,Unclear,Unclear,Unclear,"Yes, single",48.0,50.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,"The Abeta peptide used for these experiments were purchased from Covance (Dedham, MA)."
385,418,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,1.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,
386,419,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,3.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,
387,420,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,5.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,
388,421,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,10.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,
389,422,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,20.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,
390,423,MTT,Unclear,NA,No,No,Unlear,1-42,recombinant,Unclear,Unclear,"Yes, single",48.0,50.000,Not informed,100000,cell/well,,24,Not informed,Not informed,Not informed,Not informed,No differentiation,,NA,NA,NA,NA,NA,
391,424,MTT,Cell bank,ECACC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,0.500,Not informed,80000,cell/well,100.0,96,1 DMEM : 1 F12,"with L-glutamine, 15mM Hepes, penicillin 100 units/ml, streptomycin 100 μg/ml, 100x MEM non-essential aminoacids",Fetal Bovine Serum,15%,No differentiation,,NA,NA,NA,NA,NA,
392,425,MTT,Cell bank,ATCC,No,No,Medium only,1-42,synthetic,Unclear,Oligomers,"Yes, single",24.0,1.000,Not informed,10000,cell/well,100.0,96,DMEM and F12 mixture,"1% glutamine, 1% penicillin and streptomycin",Fetal Bovine Serum,10%,No differentiation,,NA,NA,NA,NA,NA,